Aspen Aerogels Inc (ASPN) Q3 2024 Earnings Report

Aspen Aerogels delivered a robust QQ3 2024 performance characterized by a step-change in revenue, margin expansion, and a clear path to higher profitability as strategic levers intensify. Revenue for the quarter was $117.34 million, up 93% year over year, driven by the EV Thermal Barrier business (PyroThin) and ongoing LNG/Cryogel momentum in Energy Industrial. The company reported an adjusted EBITDA of $25.4 million (22% margin) and a net loss of $13.0 million, with the difference largely reflecting non-operational items including debt extinguishment costs and ongoing depreciation within a capex-heavy buildout cycle. Management raised 2024 guidance to $450 million of revenue and $90 million of adjusted EBITDA, underscoring confidence in a strong post-turnaround trajectory as Plant 2 and external manufacturing reach scale. Importantly, Aspen is advancing a multi-year growth framework: convert East Providence to support PyroThin, complete external manufacturing transitions for Energy Industrial, and finance the Georgia Statesboro plant via a DoE loan facility (conditional commitment up to $670 million) while pursuing accretive, margin-rich growth in EV-related products and LNG/Cryogel offerings. The combination of a high-margin, high-growth EV barrier pipeline (Mercedes ACC win; ongoing GM Ultium ramp) and a reaccelerating Energy Industrial business provides a scalable platform with a clear cash-flow generation path once the Plant 2 investment is funded and reaccelerated. The near-term focus remains on operating discipline, protecting margins, and closing the DoE loan to unlock the Georgia manufacturing expansion, which is expected to support substantial revenue capacity and positive cash flow at moderate capacity utilization.